Plain-English translation of NCT07184502 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is a first-in-human safety study of Injection, a new treatment being tested for the first time in people. Researchers want to find out if the medication is safe, what side effects it might cause, and how the body processes it. The study involves healthy volunteers who will receive either the medication or a placebo (inactive shot) by injection under the skin.
Before a new medication can be tested in patients with specific health conditions, scientists must first confirm it is safe in healthy people. This early study helps researchers understand the right doses and safety profile before moving forward with testing in future patient populations.
You likely qualify if…
You likely don't qualify if…
You will visit the study center to receive injections under your skin, either of the new medication or placebo. Some participants receive a single dose (Part A), while others receive multiple doses over time (Part B). Throughout the study, researchers will monitor you closely with blood tests, vital signs checks, heart rhythm recordings, and physical exams to make sure the treatment is safe and to understand how your body processes it.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Australia